Clinical Significance of Programmed Death-1 Ligand-1 Expression in Patients with Non-Small Cell Lung Cancer: A 5-year-follow-up Study
- 1 November 2012
- journal article
- research article
- Published by SAGE Publications in Tumori Journal
- Vol. 98 (6), 751-755
- https://doi.org/10.1177/030089161209800612
Abstract
The programmed death-1-ligand 1 (PD-L1) has been recently suggested to play a pivotal role in the immune evasion of tumors from host immune system. In the study, we tried to reveal the clinical significance of PD-L1 in patients with non-small cell lung cancer (NSCLC), which is one of the most aggressive and intractable malignant tumors. PD-L1 expression in 120 NSCLC tissue specimens and 10 benign control samples embedded with wax were retrospectively detected by immunohistochemistry. No PD-L1 was detected in the 10 benign controls, whereas 57.5% of NSCLC tissue specimens showed PD-L1 expression. There was no relationship between PD-L1 expression and patient age, gender or histopathological type. However, PD-L1 expression was significantly correlated to the degree of tumor cell differentiation, stage of tumor node metastasis (TNM) and patient survival. Poor tumor cell differentiation and advanced TNM stage were related to higher PD-L1 expression. PD-L1-negative NSCLC patients had longer overall 5-year survival than PD-L1-positive patients (P 2 = 18.153, RR = 2.946, P <0.001). Up-regulated PD-L1 expression in NSCLC is related to the degree of tumor cell differentiation and TNM stage. PD-L1 status may be a new predictor of prognosis for patients with NSCLC.Keywords
This publication has 41 references indexed in Scilit:
- Cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2012
- B7-H1 Expression in Vestibular SchwannomasOtology & Neurotology, 2010
- Tumor progression by immune evasion in melanomaCancer, 2010
- Cancer Trends in ChinaJapanese Journal of Clinical Oncology, 2010
- Cancer immunoediting and “spontaneous” tumor regressionPathology - Research and Practice, 2010
- The New Lung Cancer Staging SystemSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2009
- New TNM classification for non-small-cell lung cancerExpert Review of Anticancer Therapy, 2009
- 7th Revision of the Declaration of Helsinki: Good News for the Transparency of Clinical TrialsCroatian Medical Journal, 2009
- Cancer immunoediting from immune surveillance to immune escapeImmunology, 2007
- B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretionNature Medicine, 1999